The contribution of immunohistochemistry in the diagnosis of pediatric neoplastic lesions in the University of Puerto Rico, School of Medicine

Immunohistochemistry has revolutionized the field of diagnostic pathology in the past fifteen years. Since then, it has been increasingly used as an adjunct to morphological diagnosis. The purpose of this retrospective analysis is to examine the value of this technique in the diagnosis of pediatric neoplasias in our laboratory. Forty eight pediatric cases, collected from January 1998 until May 1999, were reviewed, and classified in one of four categories: confirmed the morphological diagnosis, provided the definite diagnosis from a list of probable diagnoses, contributed by excluding other entities, and non-contributory. Immunohistochemistry confirmed the morphological diagnosis in 29 cases (60.4), provided the definite diagnosis from a list of probable diagnoses in 13 cases (27.1), was contributory by exclusion of other entities in 2 cases (4.2), and was non-contributory in 4 cases (8.3). In this preliminary study, we conclude that immunohistochemistry is being used in our laboratory mostly as a confirmatory tool for the definitive diagnosis of the lesions and once more exalts the utility of this technology in the field of diagnostic pathology.

Immediate transfusion reactions

Immediate transfusion reactions were characterized in recipients of 15,990 RBCs, 18,013 platelets, 409 single donor platelets, 3,451 FFP and 1,507 units of cryoprecipitate. The overall incidence of immediate reactions was 0.2. Allergic reactions occurred in 40 patients, febrile non-hemolytic in 36 patients, bacterial contamination in 2 patients, circulatory overload in 3 patients and mechanical hemolysis in one patient. Three patients had nonspecific reactions. The incidence of immediate transfusion reactions was low when compared with similar studies. Possible causes are under-reporting transfusion reactions and the use of leukoreduced components.

Evaluation of serologic markers for transfusion trasmitted infectious diseases for allogeneic blood donors in Puerto Rico

The purpose of this project is to assess the prevalence of serologic markers for transfusion transmitted infectious disease in allogeneic blood donors of the American Red Cross Blood Services (ARCBS) in Puerto Rico. Four hundred records were randomly selected from a population of 7718 first time volunteer donors from the ARCBS in P.R. covering the period from Jan. 1st to Jun. 30th, 1991. Variables obtained were: age, sex, presence of hepatitis B surface antigen (HBsAg), hepatitis B anti-core antibody (anti-HBc), hepatitis C virus antibody (anti-HCV), HIV 1/2 antibody, HTLV I/II antibody, RPR reactivity and ALT. The prevalence of serologic markers in our study is consistently higher than that found in similar studies in the U.S. population, except for HBsAg and HCV. This could be explained with the use of data from only first time volunteer donors since the prevalence is higher in this group than in repeat donors. None of the donors in this sample were positive for HBsAg probably due to the small sample. The prevalence of anti-HCV in this study is within the values found for the U.S. population.